Sanjiv Lal
Are Stem Cells the Key to Unlocking Longevity and Health?
What if the future of health optimization isn’t just about extending lifespan — but improving how our cells communicate, repair, and adapt over time? In this episode of The Better Body Lab Podcast, we explore regenerative medicine through the lens of resilience, recovery, and responsible innovation with biotechnology leader Sanjiv Lal.
Together, we examine how stem cells, exosomes, and cell factors may influence longevity, performance, and overall wellbeing. Our conversation moves beyond hype and into the realities of safety, regulation, and scientific integrity — highlighting the importance of provider-guided decision-making and foundational health practices. We also explore how the human ecology of health — the dynamic interaction between biology, environment, mindset, and daily behavior — shapes long-term vitality.
Episode Overview
Sanjiv shares his personal journey through severe illness and recovery, offering a candid perspective on the promise and complexity of regenerative therapies. We discuss the physiological role of cellular signaling, mitochondrial function, and inflammation in aging and chronic health challenges. Together, we unpack the risks of unregulated overseas treatments, common misconceptions about stem cell therapies, and emerging alternatives such as DNA-free cell factors.
This conversation emphasizes that longevity science is not about shortcuts. It is about understanding adaptation, preserving muscle and metabolic health, and building resilience at the cellular level.
What You’ll Learn in This Episode
• How stem cells function and the potential risks of immune reactions and contamination
• Differences between live stem cells, exosomes, and cell factor signaling therapies
• Why transparency, product sourcing, and regulatory oversight matter for safety
• Early warning signs of cellular dysfunction such as fatigue, inflammation, and poor recovery
• The role of mitochondria in energy regulation and performance resilience
• How chronic inflammation disrupts cellular communication and healthspan
• Ethical and philosophical considerations surrounding regenerative medicine
• Delivery methods and ideal candidates for cell-based and cell-factor therapies
• Why provider-led education is critical in navigating longevity strategies
• How regenerative approaches fit within broader health optimization and recovery frameworks
About Our Guest
Sanjiv Lal, Co-Founder and Partner at Motivant, oversees business development and sales, driving revenue growth and fostering a high-performing sales team. With 24 years of experience in pharmaceuticals, biotechnology, and molecular genetics, he has successfully founded and scaled multiple laboratories, selling two along the way. Sanjiv’s expertise in anticipating market trends and adapting to the evolving healthcare landscape positions him as a strategic industry leader.
Having held leadership roles at Fortune 500 biotechnology firms, Sanjiv has also been instrumental in growing independent labs like Marquis Labs. His recent efforts include overseeing strategic planning, sales execution, and operational processes for ventures like Rio Grande Valley Labs, contributing to over a million results to date. A firm believer in relationships, integrity, and transparency, Sanjiv emphasizes collaboration and continuous innovation within Motivant and across the biotech sector.
Holding both a Bachelor of Science and a Master of Science in Pharmaceutical Sciences from The Ohio State University, Sanjiv is passionate about leveraging advancements to bring transformative products to market, ensuring Motivant remains a leader in innovation
For information about Motivant visit:
Follow Sanjiv Lal here:
LinkedIn: https://www.linkedin.com/in/sanjiv-lal-456985149
⏱ Episode Timestamps
00:00 Risks of Overseas Stem Cell Clinics
06:44 Stem Cells Explained
08:44 Why Stem Cells Appeal for Regeneration
10:47 Limits of Traditional Medicine
12:49 Misconceptions About U.S. Treatments
15:48 Stem Cells vs. Cell Factors
18:02 Aging, Inflammation & Cell Signaling
19:37 Choosing Safe Stem Cell Therapies
20:46 Stem Cell Sources & Wharton’s Jelly
24:50 Risks of Poorly Sourced Cells
25:57 Types of Regenerative Therapies
26:32 Evaluating Product Quality
28:04 Cell Count Myths
32:02 Infectious Disease Risks
34:20 Immune Reactions & Systemic Effects
38:12 DNA-Free Cell Factor Approach
41:22 Standardization & Regulatory Safety
45:03 How Cell Factors Work
48:03 Early Signs of Cellular Decline
51:05 Pediatric Regenerative Applications
53:08 Delivery Methods for Cell Factors
54:14 Ideal Candidates for Therapy
56:23 Ethical & Philosophical Considerations
58:01 Native Cellular Healing Signals
01:00:45 Longevity Trends & Cellular Health
01:04:36 Provider-Led Longevity Education
01:06:49 Key Takeaways & Episode Wrap
